Glatiramer Acetate Injection, Solution
Product Images NDC 82983-429

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 82983-429). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajenat Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure B (Fig B)

Figure B (Fig B)
An instructional illustration showing hands preparing or handling a syringe and a medication vial or container, demonstrating the proper method for drawing or administering a subcutaneous injection.*
FDA Label Image

Figure C (Fig C)

Figure C (Fig C)
Illustrations showing recommended subcutaneous injection sites for Glatiramer Acetate injection, solution 20 mg/mL. Areas include the abdomen (avoiding about 2 inches around the belly button), back of hips and upper arms (fleshy areas below the waist and upper back portion of arms), upper back portion of arms, and thighs (about 2 inches above the knee and 2 inches below the groin).*
FDA Label Image

Figure D (Fig D)

Figure D (Fig D)
An instructional illustration showing a person's hand peeling off adhesive tape from their thigh, likely demonstrating a step related to subcutaneous injection or skin preparation.*
FDA Label Image

Figure E1 (Fig E1)

Figure E1 (Fig E1)
An instructional illustration showing a hand holding a syringe, demonstrating how to properly hold it for injection. The syringe is positioned horizontally above a surface, indicating preparation for administration.*
FDA Label Image

Figure E2 (Fig E2)

Figure E2 (Fig E2)
An instructional illustration showing a pair of hands preparing a syringe injection. One hand holds a capped syringe, and the other hand is removing or about to insert the needle cap, demonstrating proper handling of an injectable solution device.*
FDA Label Image

Figure E3 (Fig E3)

Figure E3 (Fig E3)
Illustration showing a hand holding a syringe positioned for subcutaneous injection. The syringe is oriented with the needle pointing outward and a small cap visible on a surface nearby, indicating preparation for use.*
FDA Label Image

Figure F (Fig F)

Figure F (Fig F)
An instructional illustration showing a hand pinching a fold of skin, typically used to demonstrate the proper technique for subcutaneous injection administration.*
FDA Label Image

Figure G (Fig G)

Figure G (Fig G)
An instructional illustration showing the technique for administering a subcutaneous injection in the thigh area. The image depicts a hand holding a syringe at a 90-degree angle to the skin of the thigh, demonstrating proper injection method.*
FDA Label Image

Figure H (Fig H)

Figure H (Fig H)
An instructional diagram showing the proper technique for administering a subcutaneous injection into the thigh using a syringe and needle. The illustration focuses on hand positioning and injection site on the upper leg.*
FDA Label Image

Figure I (Fig I)

Figure I (Fig I)
An instructional illustration showing a person administering a subcutaneous injection using a syringe. One hand holds the syringe vertically above the other hand, which is positioned with fingers spread on a flat surface, indicating the injection technique.*
FDA Label Image

Figure J (Fig J)

Figure J (Fig J)
Illustration showing a hand administering a subcutaneous injection using a syringe, with the needle inserted into the skin at an angle. The diagram depicts proper injection technique for subcutaneous delivery.*
FDA Label Image

Figure K (Fig K)

Figure K (Fig K)
Illustration showing a hand with two fingers extended, possibly demonstrating a pinch or injection site preparation technique related to subcutaneous administration.*
FDA Label Image

Figure L (Fig L.png)

Figure L (Fig L.png)
An illustration showing a rectangular container with a lid, depicted in simple black and white line art. The container appears to be a storage or disposal box, with a hinged or removable top, set against a shaded background.*
FDA Label Image

Blister Label (Blister Label 20mg)

Blister Label (Blister Label 20mg)
Label for Glatiramer Acetate Injection 20 mg/mL solution for subcutaneous injection. The label states once daily dosing and includes the Ajena Pharmaceuticals LLC distributor information. It specifies storage conditions as refrigerated and protects from light. Barcode and batch details are visible, with the product made in China.*
FDA Label Image

Carton (Carton 20)

Carton (Carton 20)
Packaging label for Glatiramer Acetate Injection 20 mg/mL, a subcutaneous injection by Ajent Pharmaceuticals LLC. The label indicates it is for once daily use and contains 30 single-dose pre-filled syringes. It includes dosage instructions, storage conditions, manufacturing details from Guangdong Sunshine Pharmaceutical Co., Ltd., and distribution information for Ajent Pharmaceuticals.*
FDA Label Image

Figure 1 (Fig 1)

Figure 1 (Fig 1)
Kaplan-Meier curve displaying the percentage of second exacerbation over time in days up to 1080 for two groups: Glatiramer Acetate 20 mg/mL and placebo. The vertical axis shows second exacerbation percentage, while the horizontal axis shows days from zero to 1080. The graph indicates a lower exacerbation percentage over time with Glatiramer Acetate compared to placebo, including corresponding p-value and hazard ratio details.*
FDA Label Image

Figure 2 (Fig 2)

Figure 2 (Fig 2)
A line graph comparing the cumulative number of enhancing lesions per patient over nine months between Glatiramer Acetate and placebo groups. The x-axis represents months, and the y-axis indicates the cumulative number of enhancing lesions. Two lines distinguish Glatiramer Acetate (gray) from placebo (black).*
FDA Label Image

Figure A (Fig A)

Figure A (Fig A)
An illustration showing medical supplies including a sharps disposal container, syringe in blister package, cotton balls, alcohol wipes, and an injection diary, typically used for subcutaneous injections like Glatiramer Acetate 20 mg/mL.*
FDA Label Image

Syringe Label (Label For 20mg 260119 1)

Syringe Label (Label For 20mg 260119 1)
Label for Glatiramer Acetate Injection 20 mg/mL solution for subcutaneous injection. The label includes the product NDC 82983-429, states "Rx Only," and indicates distribution by Ajenat Pharmaceuticals, LLC. It features a barcode and placeholders for lot and expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.